Diabetes TBM positions?

Discussion in 'Lexicon Pharmaceuticals' started by anonymous, Nov 23, 2018 at 10:25 AM.

Tags: Add Tags

  1. anonymous

    anonymous Guest

    FDA rejected Sotagliflozin. Guess I won't get that job. Bummer
     
  2. anonymous

    anonymous Guest

    FDA did not reject the application. Should the applicant fulfill the requests listed in the complete response letter, an approval is possible. Time will tell.
     
  3. anonymous

    anonymous Guest


    Do you have any idea about a timeline?
     
  4. anonymous

    anonymous Guest

    Likely another 6 months to a year depending on how long it takes for the company to conduct the follow up, submit it to the fda and wait for approval.
     
  5. anonymous

    anonymous Guest

    causing DkA is a serious it’s not coming to market risk
     
  6. anonymous

    anonymous Guest

    Talked to endo at Mass Gen who was laughing about this saying those clowns from Lexicon didn't know how to answer simple questions during first meeting. The medical director and ceo are known con artists so this group of docs is sending letter to fda to not approve.
     
  7. anonymous

    anonymous Guest

    yep. It all started with Sands. Don’t forget the selective to dual inhibitor change in one edit of Wiki. Some pills make you tall.......
     
  8. anonymous

    anonymous Guest

    ya we will be the second SGLT2 approved for type 1 by then! With zero coverage
     
  9. anonymous

    anonymous Guest

    this company is so pathetic that it can’t even keep it’s WIKI page up todate. SAD
     
  10. anonymous

    anonymous Guest

    will this company survive? seems like the long death row walk